Home>Topics>Companies>Boston Scientific

Boston Scientific BSX

  1. All
  2. Commentary
  3. Stock Reports
  4. Video Reports
  5. Fund Reports
  6. ETF Reports
  7. Headlines
    1. Boston Scientific deep brain stimulator gets CE Mark


      Wed, 17 Sep 2014

      Boston Scientific ( BSX +0.8% ) receives CE Mark clearance for its Vercise Deep Brain Stimulation (DBS) System for the treatment of tremor, including

    2. A Tale Of 2 Portfolios


      Sat, 13 Sep 2014

      Alcatel-Lucent, S.A. (NYSE: ALU ), Dollar Tree (NASDAQ: DLTR ), Caterpillar (NYSE: CAT ) and Boston Scientific (NYSE: BSX ) (2 purchases). The second portfolio consists of Universal Insurance Holdings (NYSE: UVE ), Gray Television

    3. Boston Scientific ordered to pay $73 million over mesh device


      Tue, 9 Sep 2014

      Sept 9 (Reuters) - A Texas jury has ordered Boston Scientific Corp to pay $73 million to a woman who said she suffered serious injuries from a transvaginal mesh device, the first loss for the device maker in one of thousands of suits over the products.

    4. Cyberonics device improves heart function after Boston flop


      Mon, 1 Sep 2014

      BARCELONA, Sept 1 (Reuters) - A nerve stimulation device from Cyberonics improved cardiac function in heart failure patients in a small clinical trial, in contrast to an unsuccessful study backed by Boston Scientific .

    5. Boston Scientific nerve device no help in heart failure study


      Sat, 30 Aug 2014

      BARCELONA, Aug 30 (Reuters) - A Boston Scientific device that stimulates the vagus nerve - a superhighway connecting the brain to the rest of the body - failed to help patients with heart failure in a mid-stage clinical trial.

    6. New Morningstar Analyst Report for ResMed Inc. (0C000008SB - USA)

      Stock Reports

      Fri, 1 Aug 2014

      device companies such as Medtronic, St. Jude and Boston Scientific . During the next five years, we expect key demographic ..... device companies such as Medtronic , St. Jude, and Boston Scientific . During the next five years, we expect key demographic

    7. Edwards Lifesciences Posts Strong 2Q on New Launches; We've Raised Our Fair Value Estimate


      Wed, 30 Jul 2014

      had cautiously anticipated rising competition now that Medtronic has entered the U.S. and St. Jude Medical and Boston Scientific have launched in Europe, Edwards showed its own strength in both markets with its rollout of Sapien XT and Sapien

    8. New Morningstar Analyst Report for CR Bard Inc

      Stock Reports

      Tue, 29 Jul 2014

      25% of claims so far.With growth in the cardiac device markets slowing, deep-pocketed competitors, such as Boston Scientific , Abbott, and Johnson & Johnson, could encroach on Bard's vascular and surgical specialties markets.The low

    9. Boston Scientific Exceeds Our Expectations in the Second Quarter


      Thu, 24 Jul 2014

      Boston Scientific released second-quarter performance that exceeded our expectations, and we plan to modestly increase our fair value estimate

    10. New Morningstar Analyst Report for Stryker Corporation

      Stock Reports

      Fri, 18 Jul 2014

      Additionally, it is not yet clear what magnitude of exposure Stryker faces for damages related to the implants.Thanks to Boston Scientific 's historical underinvestment in its neurovascular segment, Stryker must now play catch up in order to maintain

    « Prev12345Next »
    Content Partners